By STEPHANIE CLIFFORD and ANDREW POLLACK
The entrepreneur, who has been criticized for price gouging on drugs, faces securities fraud charges related to his work at MSMB Capital Management and Retrophin.
Published: December 18, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1T3zQX5
from WordPress http://ift.tt/22a72SS
via Hadi Aboukhater
No comments:
Post a Comment